World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
104
Citations
42647
World Ranking
7019
National Ranking
3688

W. Douglas Weaver publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where W. Douglas Weaver sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 322 publications — 21st percentile

21% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

W. Douglas Weaver D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where W. Douglas Weaver sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 104 D-Index — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

W. Douglas Weaver is affiliated with Ford Motor Company in the United States. Their professional activities are based in the United States, where they contribute to the automotive industry through research and development.

There is no specific information available regarding the topics of their published research, co-authors they frequently collaborate with, or publication venues in which they have appeared. Similarly, details about scholarly papers, including titles, years of publication, and venues, are not provided.

No records indicate their involvement in book publications or details about the number or nature of any books published. The main and subfields of their scientific study have not been specified either, leaving a gap in understanding their academic focus or specialization.

No main topics associated with their research work have been identified, and there are no listed awards or honors that recognize their contributions. There is no information suggesting that Weaver is deceased, implying that they are currently active or their status is unknown.

Best Publications

  • 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)

    Thomas J. Ryan;Elliott M. Antman;Neil H. Brooks;Robert M. Califf

  • Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction : A quantitative review

    W D Weaver;R J Simes;A Betriu;C L Grines

  • Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction.

    Cannon Cp;Gibson Cm;Lambrew Ct;Shoultz Da

  • ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction

    Thomas J. Ryan;Jeffrey L. Anderson;Elliott M. Antman

  • Predictors of 30-Day Mortality in the Era of Reperfusion for Acute Myocardial Infarction Results From an International Trial of 41 021 Patients

    Kerry L. Lee;Lynn H. Woodlief;Eric J. Topol;W. Douglas Weaver

  • Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.

    Karen P. Alexander;L. Kristin Newby;Christopher P. Cannon;Paul W. Armstrong

  • Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb Investigators

    J S Hochman;J E Tamis;T D Thompson;W D Weaver

  • Prehospital-Initiated vs Hospital-Initiated Thrombolytic Therapy: The Myocardial Infarction Triage and Intervention Trial

    W D Weaver;M Cerqueira;A P Hallstrom;P E Litwin

  • Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study

    Peter A McCullough;Edward F Philbin;John A Spertus;Scott Kaatz

  • Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction.

    W J Rogers;L J Bowlby;N C Chandra;W J French

  • Darapladib for preventing ischemic events in stable coronary heart disease.

    Harvey D. White;Claes Held;Ralph Stewart;Elizabeth Tarka

  • Oral ximelagatran for secondary prophylaxis after myocardial infarction: the ESTEEM randomised controlled trial

    Lars Wallentin;Robert G Wilcox;W Douglas Weaver;Håkan Emanuelsson

  • A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction: the Air Primary Angioplasty in Myocardial Infarction study

    Cindy L Grines;Donald R Westerhausen;Lorelei L Grines;J.Timothy Hanlon

  • Randomized Comparison of Coronary Thrombolysis Achieved With Double-Bolus Reteplase (Recombinant Plasminogen Activator) and Front-Loaded, Accelerated Alteplase (Recombinant Tissue Plasminogen Activator) in Patients With Acute Myocardial Infarction

    C Bode;R W Smalling;G Berg;C Burnett

  • TNK–Tissue Plasminogen Activator Compared With Front-Loaded Alteplase in Acute Myocardial Infarction Results of the TIMI 10B Trial

    Christopher P. Cannon;C. Michael Gibson;Carolyn H. McCabe;A. A. Jennifer Adgey

  • Acute coronary care in the elderly, Part II ST-segment-elevation myocardial infarction a scientific statement for healthcare professionals from the american heart association council on clinical cardiology

    Karen P. Alexander;L. Kristin Newby;Paul W. Armstrong;Christopher P. Cannon

  • ACCF/SCAI/STS/MTS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization. Commentary

    Frederick A. Masoudi;Ralph G. Brindis;W. Douglas Weaver;Timothy J. Gardner

  • Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.

    Pilote L;Califf Rm;Sapp S;Miller Dp

  • Gender Differences in the Treatment and Outcome of Acute Myocardial Infarction: Results From the Myocardial Infarction Triage and Intervention Registry

    Charles Maynard;Paul E. Litwin;Jenny S. Martin;W. Douglas Weaver

  • Ticagrelor Versus Clopidogrel in Patients With ST-Elevation Acute Coronary Syndromes Intended for Reperfusion With Primary Percutaneous Coronary Intervention A Platelet Inhibition and Patient Outcomes (PLATO) Trial Subgroup Analysis

    Philippe Gabriel Steg;Stefan James;Robert A. Harrington;Diego Ardissino

Frequent Co-Authors

Charles Maynard
Charles Maynard University of Washington
Robert M. Califf
Robert M. Califf Duke University
Christopher B. Granger
Christopher B. Granger Duke University
Alfred P. Hallstrom
Alfred P. Hallstrom University of Washington
Paul W. Armstrong
Paul W. Armstrong University of Alberta
Harvey D. White
Harvey D. White Auckland City Hospital
Eric J. Topol
Eric J. Topol Scripps Research Institute
Kenneth W. Mahaffey
Kenneth W. Mahaffey Stanford University
W. Brian Gibler
W. Brian Gibler University of Cincinnati
Judith S. Hochman
Judith S. Hochman New York University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Medicine in the USA opens doors to a range of related healthcare degrees and flexible career pathways. Aspiring healthcare professionals who seek a quicker entry into the field may consider accelerated healthcare programs. These options allow students to complete their studies faster while gaining the knowledge needed for administrative roles.

For registered nurses wanting to advance their careers, specific pathways like adn to fnp programs provide a bridge from an Associate Degree in Nursing to a Family Nurse Practitioner role—all online. This creates opportunities for higher responsibility and earning potential.

Those interested in preventive care, wellness, and nutrition can pursue an online dietitian degree. This qualification prepares graduates for essential roles in hospitals, schools, and private practice.

For those aspiring to lead healthcare organizations, exploring cahme accredited online mha programs is a smart move. Earning a Master of Health Administration online ensures a rigorous, accredited education while offering the flexibility needed by working professionals.

Best Scientists Citing W. Douglas Weaver

Trending Scientists

Recently Published Articles